Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Real-World Clinical Outcomes in Patients with Relapse and Refractory Multiple Myeloma Received VTD-PACE Treatment in the Era of Monoclonal Antibody

Moe Yogo, Taku Kikuchi, Nobuhiro Tsukada, Kodai Kunisada, Yuki Okda, Kota Sato, Mizuki Ogura, Tomomi Takei, Yu ABE, Kenshi Suzuki, Tadao Ishida

Blood (2023) 142 (Supplement 1): 6625.

https://doi.org/10.1182/blood-2023-174725

Published: 2023

Journal Articles

Subcutaneous Isatuximab Administration By an on-Body Delivery System (OBDS) in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Phase 1b Expansion Study Results

Hang Quach, Gurdeep Parmar, Enrique M. Ocio, H. Miles Prince, Albert Oriol, Nobuhiro Tsukada, Kazutaka Sunami, Pierre Bories, Sumit Madan, Dorothee Semiond, Disa Yu, Sandrine Macé, Florence Suzan, Philippe Moreau

Blood (2022) 140 (Supplement 1): 4412–4414.

https://doi.org/10.1182/blood-2022-166840

Published: 2022

Journal Articles

Allogeneic Stem Cell Transplantation Conditioned with Myeloablative Regimens Containing Total Body Irradiation in Adolescent and Young Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Who Were Treated with Pediatric-Type Chemotherapy

Blood (2021) 138 (Supplement 1): 2283.

https://doi.org/10.1182/blood-2021-151855

Published: 2021

Journal Articles

Efficacy of Modified Vrd-Lite for Transplant Ineligible Multiple Myeloma

Mizuki Ogura, MDPhD, Tadao Ishida, MDPhD, Moe Nomura, Hirofumi Irita, Junichiro Nashimoto, Kota Sato, MDPhD, Kanji Miyazaki, MDPhD, Yu Abe, MD, Nobuhiro Tsukada, MDPhD, Kenshi Suzuki, MD PhD

Blood (2020) 136 (Supplement 1): 4.

https://doi.org/10.1182/blood-2020-143459

Published: 2020

Journal Articles

The Clinical Features of Multiple Myeloma with AL Amyloidosis

Junichiro Nashimoto, Moe Nomura, Hirofumi Irita, Kota Sato, MDPhD, Kanji Miyazaki, MDPhD, Mizuki Ogura, MDPhD, Yu Abe, MD, Nobuhiro Tsukada, MDPhD, Tadao Ishida, MDPhD, Kenshi Suzuki, MD PhD

Blood (2020) 136 (Supplement 1): 10.

https://doi.org/10.1182/blood-2020-142362

Published: 2020

Journal Articles

Changing Trends in the Risk Factors of Secondary Primary Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma before and after the Introduction of Proteasome Inhibitors/Immunomodulatory Agents

Hiroyuki Takamatsu, MD PhD, Shohei Mizuno, MD PhD, Tsutomu Takahashi, MD PhD, Shin-Ichi Fuchida, MD PhD, Ichiro Hanamura, MD PhD, Fumihiko Nakamura, MD PhD, Takehiko Mori, MD PhD, Yuta Katayama, MD PhD, Noriko Doki, MD PhD, Nobuhiro Tsukada, MD PhD, Tatsuo Ichinohe, Yoshinobu Kanda, MD PhD, Yoshiko Atsuta, MD PhD, Kazutaka Sunami, MD PhD

Blood (2019) 134 (Supplement_1): 4358.

https://doi.org/10.1182/blood-2019-123607

Published: 2019

Journal Articles

MRD Detection in Myeloma Cells: Comparison between Inexpensive 1-Tube 10 Color Multiparameter Flow Cytometry and Euroflow Multiparameter Flow Cytometry

Kiyoshi Okazuka, MD, Tadao Ishida, MD PhD, Jun Sakamoto, Nobuhiro Tsukada, MD PhD, Kenshi Suzuki, MD PhD

Blood (2019) 134 (Supplement_1): 1832.

https://doi.org/10.1182/blood-2019-123900

Published: 2019

Journal Articles

Retrospective Analysis of the Efficacy and Safety of Modified Bortezomib-Lenalidomide-Dexamethasonelite (modified RVD-lite) Therapy for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Kiyoshi Okazuka, MD, Tadao Ishida, MDPhD, Junichiro Nashimoto, MD, Takao Yogo, MD, Kanji Miyazaki, MD, Kota Sato, MDPhD, Yui Uto, MD PhD, Mizuki Ogura, MDPhD, Yumiko Yoshiki, MDPhD, Yu ABE, MD, Nobuhiro Tsukada, MDPhD, Kenshi Suzuki, MD PhD

Blood (2018) 132 (Supplement 1): 1961.

https://doi.org/10.1182/blood-2018-99-112294

Published: 2018

Journal Articles

Retrospective Analysis of High-Dose Melphalan and Autologous Stem Cell Transplantation for Systemic Light-Chain Amyloidosis: A Single Center 63 Cases

Kiyoshi Okazuka, MD, Nobuhiro Tsukada, Kota Sato, MD, Kanji Miyazaki, Yumiko Yoshiki, Yu Abe, MD, Tadao Ishida, MD, Kenshi Suzuki

Blood (2017) 130 (Supplement 1): 4542.

https://doi.org/10.1182/blood.V130.Suppl_1.4542.4542

Published: 2017

Journal Articles

10 Years History of Cost-Effectiveness for 209 Newly Diagnosed Multiple Myeloma Patients at a Single-Institute in Japan

Kenshi Suzuki, MD PhD, Tomofumi Yamamoto, Masahiro Ikeda, MD, Tomomi Takei, MD, Nobuhiro Tsukada, MD PhD, Tadao Ishida, MD PhD, Arimi Ueda, Daiju Ichikawa, PhD, Maiko Matsushita, MD PhD, Yutaka Hattori, MD PhD

Blood (2016) 128 (22): 5620.

https://doi.org/10.1182/blood.V128.22.5620.5620

Published: 2016

Journal Articles

Difference of Treatment Outcomes in AL Amyloidosis and Multiple Myeloma with / without Translocation (11;14)

Kenshi Suzuki, Miho Kasuga, trainee, Kanji Miyazaki, MD, Sohsuke Meshitsuka, MD, Yu ABE, MD, Yumiko Yoshiki, MD PhD, Nobuhiro Tsukada, MD PhD

Blood (2015) 126 (23): 4224.

https://doi.org/10.1182/blood.V126.23.4224.4224

Published: 2015

Journal Articles

The Impact of Donor Age on Outcome after Unrelated Bone Marrow Transplantation: Comparison with Unrelated Cord Blood Transplantation

Sachiko Seo, MD PhD, Junya Kanda, Yoshiko Atsuta, MDPhD, Naoyuki Uchida, Kazuteru Ohashi, MD FACP, Takahiro Fukuda, MD, Satoshi Takahashi, MD,PhD, Yukiyasu Ozawa, MD, Makoto Onizuka, MD PhD, Minoko Takanashi, MD PhD, Nobuhiro Tsukada, MD PhD, Shunichi Kato, MD PhD, Fumihiko Kimura, MD, Yoshinobu Kanda, MD PhD, Koichi Miyamura, MD PhD

Blood (2015) 126 (23): 154.

https://doi.org/10.1182/blood.V126.23.154.154

Published: 2015

Journal Articles

Comparison of Outcomes of Unrelated BM and CB Transplants in Young Adult Leukemia Patients. Updated Results of Japanese Registration Study

Seitaro Terakura, MD PhD, Yoshiko Atsuta, MD, Nobuhiro Tsukada, MD PhD, Takeshi Kobayashi, MD, Masatsugu Tanaka, MD, Junya Kanda, Kazuteru Ohashi, MD PhD, Takahiro Fukuda, MD, Naoyuki Uchida, MD PhD, Takahashi Satoshi, MD, Tokiko Nagamura-Inoue, Yasuo Morishima, MD, Koichi Miyamura

Blood (2014) 124 (21): 45.

https://doi.org/10.1182/blood.V124.21.45.45

Published: 2014

Journal Articles

Impact Of Novel Agents To The Additional-Chromosomal Abnormalities In Patients With Multiple Myeloma

Kenshi Suzuki, MD, PhD, Yu Abe, Kanji Miyazaki, Rieko Sekine, MD, PhD, Nobuhiro Tsukada, MD, PhD, Yutaka Hattori, MD, PhD, Airi Hamano, Sumito Shingaki

Blood (2013) 122 (21): 3225.

https://doi.org/10.1182/blood.V122.21.3225.3225

Published: 2013

Journal Articles

Discovery Research On the Effects of Continuous Administration of Bortezomib Maintenance Therapy to Treat Patients with Relapsed and Refractory Multiple Myeloma - Analysis of Background Factors That Affect the Continuity of Therapy-

Kenshi Suzuki, MD, PhD, Nobuhiro Tsukada, MD, PhD, Yu Abe, MD, Rieko Sekine, MD, PhD, Yasunori Nakagawa, MD, PhD

Blood (2012) 120 (21): 1866.

https://doi.org/10.1182/blood.V120.21.1866.1866

Published: 2012

Journal Articles

The Impact of HLA Haplotype Matching for Mismatched Cord Blood Transplantation.

Satoshi Takahashi, M.D., Jun Ooi, M.D., Nobuhiro Tsukada, M.D., Seiko Kato, M.D., Aki Sato, M.D., Toshiro Kawakita, M.D., Yasuyuki Nagata, M.D., Maki Monna-Ooiwa, Arinobu Tojo, MD, Takuhiro Yamaguchi, Ph.D., Satoko Morishima, M.D., Yasuo Morishima, M.D., Shigetaka Asano, M.D.

Blood (2009) 114 (22): 1206.

https://doi.org/10.1182/blood.V114.22.1206.1206

Published: 2009

Journal Articles

Flow Cytometric Analysis of Donor-Recipient Chimerism Using Anti-HLA Antibody after HLA-Mismatched Cord Blood Transplantation.

Satoshi Takahashi, MD, Nobukazu Watanabe, MD, PhD, Misako Iezaki, Takashi Shibata, Jun Ooi, MD, Akira Tomonari, MD, Nobuhiro Tsukada, MD, Takaaki Konuma, MD, Takeshi Kobayashi, MD, Aki Sato, MD, Seiko Kato, MD, Hiromitsu Nakauchi, MD, PhD

Blood (2007) 110 (11): 2008.

https://doi.org/10.1182/blood.V110.11.2008.2008

Published: 2007

Journal Articles

The Comparative Analysis of Bone Marrow Transplantation and Cord Blood Transplantation from Unrelated Donors in Patients with Myelodysplastic Syndrome in Japan.

Satoshi Takahashi, MD, Takuhiro Yamaguchi, Ph.D., Jun Ooi, M.D., Akira Tomonari, M.D., Nobuhiro Tsukada, M.D., Takaaki Konuma, M.D., Tokiko Nagamura, M.D., Shunichi Kato, M.D., Takakazu Kawase, M.D., Yasuo Morishima, M.D., Shigetaka Asano, M.D.

Blood (2007) 110 (11): 2012.

https://doi.org/10.1182/blood.V110.11.2012.2012

Published: 2007

Journal Articles

Unrelated Cord Blood Transplantation Using Myeloablative Regimen for Acute Leukemia Patients Aged between 50 and 55 Years: Single Institutional Retrospective Comparison with Patients Less Than 50 Years of Age.

Takaaki Konuma, Satoshi Takahashi, Jun Ooi, Akira Tomonari, Nobuhiro Tsukada, Seiko Kato, Maki Oiwa-Monna, Kaoru Uchimaru, Arinobu Tojo, Takuhiro Yamaguchi, Shigetaka Asano

Blood (2007) 110 (11): 2013.

https://doi.org/10.1182/blood.V110.11.2013.2013

Published: 2007

Journal Articles

Low Incidence of Cytomegalovirus Infection Associated with Rapid Cell-Mediated Immune Reconstitution after Cord Blood Transplantation Using Full Conditioning Regimen Containing 12Gy Total Body Irradiation.

Satoshi Takahashi, MD, Jun Ooi, M.D., Akira Tomonari, M.D., Nobuhiro Tsukada, M.D., Takaaki Konuma, M.D., Takeshi Kobayashi, M.D., Aki Sato, M.D., Arinobu Tojo, M.D., Nobukazu Watanabe, M.D., Hiromitsu Nakauchi, M.D., Shigetaka Asano, M.D.

Blood (2006) 108 (11): 2926.

https://doi.org/10.1182/blood.V108.11.2926.2926

Published: 2006

NARROW

Real-World Clinical Outcomes in Patients with Relapse and Refractory Multiple Myeloma Received VTD-PACE Treatment in the Era of Monoclonal Antibody

Subcutaneous Isatuximab Administration By an on-Body Delivery System (OBDS) in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Phase 1b Expansion Study Results

Allogeneic Stem Cell Transplantation Conditioned with Myeloablative Regimens Containing Total Body Irradiation in Adolescent and Young Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Who Were Treated with Pediatric-Type Chemotherapy

Efficacy of Modified Vrd-Lite for Transplant Ineligible Multiple Myeloma

The Clinical Features of Multiple Myeloma with AL Amyloidosis

Changing Trends in the Risk Factors of Secondary Primary Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma before and after the Introduction of Proteasome Inhibitors/Immunomodulatory Agents

MRD Detection in Myeloma Cells: Comparison between Inexpensive 1-Tube 10 Color Multiparameter Flow Cytometry and Euroflow Multiparameter Flow Cytometry

Retrospective Analysis of the Efficacy and Safety of Modified Bortezomib-Lenalidomide-Dexamethasonelite (modified RVD-lite) Therapy for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Retrospective Analysis of High-Dose Melphalan and Autologous Stem Cell Transplantation for Systemic Light-Chain Amyloidosis: A Single Center 63 Cases

10 Years History of Cost-Effectiveness for 209 Newly Diagnosed Multiple Myeloma Patients at a Single-Institute in Japan

Difference of Treatment Outcomes in AL Amyloidosis and Multiple Myeloma with / without Translocation (11;14)

The Impact of Donor Age on Outcome after Unrelated Bone Marrow Transplantation: Comparison with Unrelated Cord Blood Transplantation

Comparison of Outcomes of Unrelated BM and CB Transplants in Young Adult Leukemia Patients. Updated Results of Japanese Registration Study

Impact Of Novel Agents To The Additional-Chromosomal Abnormalities In Patients With Multiple Myeloma

Discovery Research On the Effects of Continuous Administration of Bortezomib Maintenance Therapy to Treat Patients with Relapsed and Refractory Multiple Myeloma - Analysis of Background Factors That Affect the Continuity of Therapy-

The Impact of HLA Haplotype Matching for Mismatched Cord Blood Transplantation.

Flow Cytometric Analysis of Donor-Recipient Chimerism Using Anti-HLA Antibody after HLA-Mismatched Cord Blood Transplantation.

The Comparative Analysis of Bone Marrow Transplantation and Cord Blood Transplantation from Unrelated Donors in Patients with Myelodysplastic Syndrome in Japan.

Unrelated Cord Blood Transplantation Using Myeloablative Regimen for Acute Leukemia Patients Aged between 50 and 55 Years: Single Institutional Retrospective Comparison with Patients Less Than 50 Years of Age.

Low Incidence of Cytomegalovirus Infection Associated with Rapid Cell-Mediated Immune Reconstitution after Cord Blood Transplantation Using Full Conditioning Regimen Containing 12Gy Total Body Irradiation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only